Click Here to Learn More About trial interactive’s mobile-first CTMS
TransPerfect Trial Interactive Innovation
Wednesday, June 23, 2021 | 11:37 AM
If you were around the clinical trial industry in the late 2000s when Trial Interactive was born, you know the internal struggle of trying to digitize procedures. Most of us were still using Blackberrys or flip phones, and convincing management to abandon paper and move to an electronic document management system seemed daunting. Luckily, we don’t come across that struggle as often now.
Instead, we strive to simplify and modernize the processes we have in place. An interoperable, connected, and streamlined platform that can manage all aspects of a clinical trial has become mandatory. If last year showed us anything about our industry, it’s that the time to push electronic technology was five years ago. Now, we need to ensure all processes are able to run and can be accessed remotely as we make up for time lost.
The Trial Interactive 10.2 release presents another wave of technology seeking to push boundaries through machine learning (ML), artificial intelligence (AI), and making the unexpected the standard.
Transparency and clear delivery of information is critical when trying to manage clinical trial documentation. TI 10.2 Dashboards provide even more flexibility to what was already in place, including:
Using milestones only for managing timelines is a thing of the past. Our Events Manager is a new way to manage amendments, milestones, and any other eTMF changes that occur during the clinical trial, which provides a more comprehensive eTMF Health and Completeness View:
The standard set of TMF metadata is “mappable” from TI document types; however, the 10.2 system now makes this information available for better metadata exports and improved classification. For eTMF rooms, this metadata is now included with each document type in a set of virtual fields including:
TI 10.2 continues to make eTMF best practices the forefront of feature and UX design inspiration:
Site activation can be held up by many process issues. Our 10.2 release looks to speed site activation through clarity and efficiency:
Trial Interactive 10.2 looks to continue many of the successes of our past releases and answer some of the requests from our users:
Over the past few years, we’ve often discussed not what AI and ML can do, but what it can’t do. Many claims are made about AI and ML processes and capabilities, but Trial Interactive focuses on real-world applications for document ID and metadata extraction, pushing the limits of AI and ML capabilities and perfecting the things they do well, including:
To learn more about the key features of TI 10.2 or to speak with us about your clinical trial documentation needs, contact us at email@example.com.